International
The lack of new antibiotics will have have an effect worldwide, not least in the developing world where we are already striving to fight routine infections and infections in neglected disease areas such as Tuberculosis.
Antibiotic Action is seeking to establish international partnerships with organisations worldwide – through our combined efforts we can bring about change and ensure we make the difference that is needed.
Please support us by signing up as a partner and lending your support, or the support of your organisation to Antibiotic Action.
Sharon Ladin, director of the Pew Health Group’s Antibiotics and Innovation Project, issued the following statement regarding the bipartisan, bicameral Generating Antibiotic Incentives Now (GAIN) Act, introduced today by Sen. Richard Blumenthal (D-Conn.) and Sen. Bob Corker (R-Tenn.). The bill is a companion to H.R. 2182 and contains provisions to incentivize the creation of new antibiotics [...]
The Australian Society for Infectious Diseases (ASID) and Australian Society for Antimicrobials (ASA) combined forces in February 2011 host the Summit on Antimicrobial Resistance. The Summit examined, amongst other issues, how to address the decrease in research into and the development of new, effective antibiotics and the increasing rates of multiresistant bacteria that cannot be treated with currently available antibiotics. In their website address about the conference [...]
On 22nd September 2011 the Pew Health Group, the Infectious Diseases Society of America and the Pharmaceutical Research and Manufacturers of America co-hosted the seminar Reviving the Pipeline of Life-Saving Antibiotics: Exploring Solutions to Spur Innovation. The podcast of the meeting can be viewed here.
Andreas Heddini, Director of ReAct, describes European moves to regenerate and incentivise discovery and development of new antibiotics In order to kick-start the policy discussions for how to incentivize research and development of new antibiotics, Sweden initiated an expert conference during its Presidency of the European Union in 2009. ReAct was part of the organizing [...]
The Infectious Diseases Society of America (IDSA) has applauded the Antibiotic Action campaign, calling it a bold and imaginative way forward in addressing an issue of global importance. IDSA, a U.S. based medical society representing infectious diseases physicians and scientists, has long recognised the imbalance between the dwindling antibacterial drug pipeline and the significant clinical need for new antibiotics [...]
